| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |